Personalized Adaptive Cortical Electro-Stimulation redefines how neuromodulation therapies are delivered.
This innovative approach integrates the precise targeting capabilities of the Bullsai platform with a novel minimally invasive delivery approach therapy designed to provide sustainable relief. Leveraging our FDA 510(k) cleared Bullsai technology, PACE creates individualized treatment protocols tailored to each patient’s unique brain circuitry.
PACE is currently in clinical development for treatment-resistant depression, with future applications in other neuropsychiatric and pain disorders.
*PACE is currently under clinical development. Statements on this page are intended as forward looking statements and not claims about the current state of the product.
Leveraging Bullsai and a novel minimally-invasive delivery approach
Pace builds on our FDA 510(k) cleared Bullsai Identify platform that creates detailed functional brain maps unique to each patient. These maps guide personalized, precise targeting of neuromodulation, while our adaptive algorithms interpret real-time feedback to optimize stimulation parameters. This closed-loop approach ensures therapy is always precisely tailored to the individual patient’s brain.
Revolutionary, minimally invasive delivery approach designed to deliver durable results.
“We now understand that most neuropsychiatric disorders involve dysfunction in distributed brain networks or circuits. In response multiple neuromodulation approaches are being pursued as novel therapies to restore the balance of activity across affected brain networks. These emerging technologies all rely on advanced imaging to map structural and functional connections in individual patients in order to personalize the targeting of neuromodulation and measure its effects.”
“We now understand that most neuropsychiatric disorders involve dysfunction in distributed brain networks or circuits.
In response multiple neuromodulation approaches are being pursued as novel therapies to restore the balance of activity across affected brain networks. These emerging technologies all rely on advanced imaging to map structural and functional connections in individual patients in order to personalize the targeting of neuromodulation and measure its effects.”
Leo Sugrue, UCSF
Pioneering precision neuromodulation therapies
Turing Medical enhances neuromodulation therapies by efficiently integrating personalized and precise image-based targeting into existing clinical workflows and is developing a revolutionary, minimally-invasive neuromodulation therapy.
Learn more about how we are revolutionizing neuromodulation therapy.
Join our passionate team of physicians, neuroscientists, engineers and entrepreneurs.
We Are Transforming Neuromodulation Therapy.
